Whalesbook
Global brokerage UBS has initiated coverage on Shaily Engineering Plastics with a 'Buy' rating and a ₹4,000 target price, forecasting a 60.2% upside. UBS believes the market is underestimating Shaily's potential, citing multiple growth drivers including strong traction in consumer and industrial segments supplying clients like IKEA and P&G, potential benefits from a favourable India-US trade deal, and significant new opportunities in the high-barrier GLP-1 drug device market. UBS also highlights Shaily's strategic entry into the GLP-1 drug market, projecting substantial revenue and EBITDA growth from generic GLP-1 devices, where it partners with 23-24 global pharma companies.